Indian J Nephrol Close
 

Figure 4: Kaplan-meier analysis of patient and graft survival after kidney transplant. (a) Graft survival (in months) between All 100 ABOi (Green) and ABOc (Blue) in the study (P = 0.03) which is lower in the incompatible group. (b) Patient Survival (in months) between All 100 ABOi (Green) and ABOc (Blue) in the study (P = 0.03) which is lower in the incompatible group. (c) Graft survival amongst latest 50 Transplants inABOi (Green) and ABOc (Blue) transplants (P = 0.09). (d) Graft survival amongst First 50 Transplants in ABOi (Green) and ABOc (Blue) transplants (P = 0.008). In the graphs above the number of observations can be seen on the timeline

Figure 4: Kaplan-meier analysis of patient and graft survival after kidney transplant. (a) Graft survival (in months) between All 100 ABOi (Green) and ABOc (Blue) in the study (<i>P</i> = 0.03) which is lower in the incompatible group. (b) Patient Survival (in months) between All 100 ABOi (Green) and ABOc (Blue)  in the study (<i>P</i> = 0.03) which is lower in the incompatible group. (c) Graft survival amongst latest 50 Transplants inABOi (Green) and ABOc (Blue) transplants (<i>P</i> = 0.09). (d) Graft survival amongst First 50 Transplants in ABOi (Green) and ABOc (Blue) transplants (<i>P</i> = 0.008). In the graphs above the number of observations can be seen on the timeline